NBSE - NeuBase Therapeutics GAAP EPS of -$1.04 beats by $0.04
- NeuBase Therapeutics press release ( NASDAQ: NBSE ): FY GAAP EPS of -$1.04 beats by $0.04 .
- As of September 30, 2022, the Company had cash and cash equivalents of approximately $23.2 million, compared with approximately $52.9 million as of September 30, 2021.
- Shares +5% PM.
For further details see:
NeuBase Therapeutics GAAP EPS of -$1.04 beats by $0.04